Curis
CRIS
#11190
Rank
S$2.08 M
Marketcap
S$0.86
Share price
-5.38%
Change (1 day)
-56.39%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): S-$18.37

According to Curis's latest financial reports the company's current EPS (TTM) is S-$18.21. In 2025 the company made an earnings per share (EPS) of S-$30.49 an increase over its 2024 EPS that were of S-$180.02.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$18.37-39.74%
2025S-$30.49-83.07%
2024S-$180.02-22.15%
2023S-$231.24-26.17%
2022S-$313.1922.3%
2021S-$256.08-25.37%
2020S-$343.15-30.93%
2019S-$496.80-2.02%
2018S-$507.04
2016S-$1,152-10%
2015S-$1,280138.1%
2014S-$537.7740%
2013S-$384.12-25%
2012S-$512.1666.67%
2011S-$307.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.97-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.81-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.23-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.57-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$4.07-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$4.40-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA